Selective reduction of central pulse pressure under angiotensin blockage in SHR: Role of the fibronectin-α5β1 integrin complex

American Journal of Hypertension

Volumn 22, Issue 7, 2009, Pages 711-717

  Kakou, Augustine ^a,b   Bézie, Yvonnick ^c   Mercier, Nathalie ^a,b   Louis, Huguette ^a,b   Labat, Carlos ^a,b   Challande, Pascal ^d   Lacolley, Patrick ^a,b   Safar, Michel E ^e,f,g  

^a INSERM   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Assistance Publique Hpitaux de Paris   (France)

^g HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN; FIBRONECTIN; TRANDOLAPRIL; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTERIAL STIFFNESS; ARTERIAL WALL THICKENING; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CAROTID ARTERY; DOPPLER ECHOGRAPHY; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PULSE PRESSURE; RAT; SYSTOLIC BLOOD PRESSURE; YOUNG MODULUS;

AMLODIPINE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; FIBRONECTINS; INDOLES; INTEGRIN ALPHA5BETA1; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 67649311802     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.87     Document Type: Article

References (40)

1. Staessen JA, Li Y, Thijs L, Wang JG. Changing concepts on the role of blood pressure reduction in cardiovascular prevention. In Safar ME, O'Rourke M (eds), Arterial Stiffness in Hypertension: Handbook of Hypertension. Elsevier: Edinburgh, UK, 2006, pp. 485-502.
2. Birns J, Markus H, Kalra L. Blood pressure reduction for vascular risk: is there a price to be paid? Stroke 2005; 36:1308-1313.
3. Black HR. The paradigm has shifted, to systolic blood pressure. Hypertension 1999; 34:386-387.
4. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99.
5. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-1225.
6. Koffi I, Lacolley P, Kirchengaast M, Pomiès JP, Laurent S, Benetos A. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats. Eur J Pharmacol 1998; 361:51-60.
7. Labat C, Lacolley P, Lajemi M, de Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension 2001; 38:439-443.
8. Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, Solomon SD, Domanski MJ, Jablonski KA, Rice MM, Pfeffer MA. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension 2007; 49:1271-1277.
9. Epstein M. Calcium antagonists in the management of hypertension. In Epstein M (ed), Calcium Antagonists in Clinical Medicine. Henley & Belfus: Philadelphia, PA, 1998, pp. 155-176.
10. Van Zweiten P (ed). Calcium entry blockers (calcium antagonists). In Handbook of Hypertension. Elsevier: Amsterdam, Netherlands, 1984, pp. 331-342.
11. Siragy HM. Angiotensin II compartmentalization within the kidney: effects of salt diet and blood pressure alterations. Curr Opin Nephrol Hypertens 2006; 15:50-53.
12. Topouchian J, Asmar R, Sayegh F, Rudnicki A, Benetos A, Bacri AM, Safar ME. Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke 1999; 30:1056-1064.
13. Heerkens EH, Shaw L, Ryding A, Brooker G, Mullins JJ, Austin C, Ohanian V, Heagerty AM. AlphaV integrins are necessary for eutrophic inward remodeling of small arteries in hypertension. Hypertension 2006; 47:281-287.
14. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000; 36:312-318.
15. Louis H, Kakou A, Regnault V, Labat C, Bressenot A, Gao-Li J, Gardner H, Thornton SN, Challande P, Li Z, Lacolley P. Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol 2007; 293:H2597-H2604.
16. Bézie Y, Lamazière JM, Laurent S, Challande P, Cunha RS, Bonnet J, Lacolley P. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998; 18:1027-1034.
17. Lacolley P, Poitevin P, Koen R, Levy BI. Different effects of calcium antagonists on fluid filtration of large arteries and albumin permeability in spontaneously hypertensive rats. J Hypertens 1998; 16:349-355.
18. Sharifi AM, Li JS, Endemann D, Schiffrin EL. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 1998; 16:457-466.
19. Duguay D, Pesant S, Deschepper CF, deBlois D. Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine. J Hypertens 2007; 25:1291-1299.
20. Yamazaki T, Komuro I, Zou Y, Kudoh S, Shiojima I, Mizuno T, Hiroi Y, Nagai R, Yazaki Y. Efficient inhibition of the development of cardiac remodeling by a long-acting calcium antagonist amlodipine. Hypertension 1998; 31:32-38.
21. Lacolley P, Osborne-Pellegrin M, Labat C, Challande P. Animal models for studies of arterial stiffness. In Safar ME, O'Rourke MF (eds), Handbook of Hypertension. Elsevier: Edinburgh, 2006, pp. 175-190.
22. Stein H, Gatter K, Asbahr H, Mason DY. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 1985; 52:676-683.
23. Contard F, Sabri A, Glukhova M, Sartore S, Marotte F, Pomies JP, Schiavi P, Guez D, Samuel JL, Rappaport L. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 1993; 22:665-676.
24. Glukhova MA, Thiery JP. Fibronectin and integrins in development. Semin Cancer Biol 1993; 4:241-249.
25. Lamaziere JM, Lavallee J, Zunino C, Larrue J. Semiquantitative study of the distribution of two cellular antigens by computer-directed color analysis. Lab Invest 1993; 68:248-252.
26. Mercier N, Osborne-Pellegrin M, El Hadri K, Kakou A, Labat C, Loufrani L, Henrion D, Challande P, Jalkanen S, Fève B, Lacolley P. Carotid arterial stiffness, elastic fibre network and vasoreactivity in semicarbazide-sensitive amine-oxidase null mouse. Cardiovasc Res 2006; 72:349-357.
27. Pauca AL, Wallenhaupt SL, Kon ND, Tucker WY. Does radial artery pressure accurately reflect aortic pressure? Chest 1992; 102:1193-1198.
28. Nichols WW, O'Rourke M. McDonald's Blood Flow in Arteries Theoretical, Experimental and Clinical Principles, 4th edn. Arnold: London/Sydney/ Auckland, 1998, pp. 54-401.
29. Cosson E, Herisse M, Laude D, Thomas F, Valensi P, Attali JR, Safar ME, Dabire H. Aortic stiffness and pulse pressure amplification in Wistar-Kyoto and spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2007; 292:H2506-H2512.
30. Berry CL, Greenwald SE. Effects of hypertension on the static mechanical properties and chemical composition of the rat aorta. Cardiovasc Res 1976; 10:437-451.
31. Lévy BI, el Fertak L, Pieddeloup C, Barouki F, Safar ME. Role of endothelium in the mechanical response of the carotid arterial wall to calcium blockade in spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 1993; 11:57-63.
32. Levy BI, Duriez M, Phillipe M, Poitevin P, Michel JB. Effect of chronic dihydropyridine (isradipine) on the large arterial walls of spontaneously hypertensive rats. Circulation 1994; 90:3024-3033.
33. Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar M, Camilleri JP. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 1988; 63:227-239.
34. Marque V, Kieffer P, Atkinson J, Lartaud-Idjouadiene I. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. Hypertension 1999; 34:415-422.
35. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of e plerenone. Circulation 2002; 106:2848-2853.
36. Bardy N, Merval R, Benessiano J, Samuel JL, Tedgui A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res 1996; 79:70-78.
37. Saouaf R, Takasaki I, Eastman E, Chobanian AV, Brecher P. Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. J Clin Invest 1991; 88:1182-1189.
38. Tamura K, Chiba E, Yokoyama N, Sumida Y, Yabana M, Tamura N, Takasaki I, Takagi N, Ishii M, Horiuchi M, Umemura S. Renin-angiotensin system and fibronectin gene expression in Dahl Iwai salt-sensitive and salt-resistant rats. J Hypertens 1999; 17:81-89.
39. Ingber DE. Cellular mechanotransduction: putting all the pieces together again. FASEB J 2006; 20:811-827.
40. Sun Z, Martinez-Lemus LA, Trache A, Trzeciakowski JP, Davis GE, Pohl U, Meininger GA. Mechanical properties of the interaction between fibronectin and alpha5beta1-integrin on vascular smooth muscle cells studied using atomic force microscopy. Am J Physiol Heart Circ Physiol 2005; 289:H2526-H2535.